U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H13FN4O
Molecular Weight 236.2455
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AM-1476 free base

SMILES

C[C@@H]1CN(N=C1C2=CC=C(F)C=C2O)C(N)=N

InChI

InChIKey=AQXHIDRAVIMBME-ZCFIWIBFSA-N
InChI=1S/C11H13FN4O/c1-6-5-16(11(13)14)15-10(6)8-3-2-7(12)4-9(8)17/h2-4,6,17H,5H2,1H3,(H3,13,14)/t6-/m1/s1

HIDE SMILES / InChI

Molecular Formula C11H13FN4O
Molecular Weight 236.2455
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 20:51:51 GMT 2025
Edited
by admin
on Wed Apr 02 20:51:51 GMT 2025
Record UNII
BT6AF27CDX
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AM1476 free base
Preferred Name English
AM-1476 free base
Code English
(4R)-3-(4-fluoro-2-hydroxyphenyl)-4-methyl-4,5-dihydro-1H-pyrazole-1-carboximidamide
Systematic Name English
Code System Code Type Description
PUBCHEM
171037445
Created by admin on Wed Apr 02 20:51:51 GMT 2025 , Edited by admin on Wed Apr 02 20:51:51 GMT 2025
PRIMARY
FDA UNII
BT6AF27CDX
Created by admin on Wed Apr 02 20:51:51 GMT 2025 , Edited by admin on Wed Apr 02 20:51:51 GMT 2025
PRIMARY
CAS
2056001-90-0
Created by admin on Wed Apr 02 20:51:51 GMT 2025 , Edited by admin on Wed Apr 02 20:51:51 GMT 2025
NON-SPECIFIC STEREOCHEMISTRY
Related Record Type Details
TARGET -> INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY
Treatment of systemic sclerosis